(Q38168477)

30 August 2017

title

Dosing of enoxaparin for venous thromboembolism prophylaxis in obese patients (English)

1 reference

30 August 2017

0 references

venous thromboembolism

1 reference

Kristine C Willett

1

1 reference

30 August 2017

Mohammad Alsharhan

series ordinal

2

1 reference

30 August 2017

Cheryl Durand

series ordinal

3

1 reference

30 August 2017

Maryann R Cooper

series ordinal

4

1 reference

30 August 2017

language of work or name

English

0 references

publication date

3 December 2013

1 reference

Annals of Pharmacotherapy

30 August 2017

published in

1 reference

30 August 2017

volume

47

1 reference

30 August 2017

issue

12

1 reference

30 August 2017

page(s)

1717-1720

1 reference

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Incidences of obesity and extreme obesity among US adults: findings from the 2009 Behavioral Risk Factor Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Development of a dosing strategy for enoxaparin in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Dosing and monitoring of low-molecular-weight heparins in special populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Soci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013507902

21 January 2018

Identifiers

DOI

10.1177/1060028013507902

1 reference

30 August 2017

1 reference